Objective: To identify risk factors for death and respiratory failure in persons with penicillin-sensitive pneumococcal bacteremia and pneumonia from data available at initial clinical evaluation. 
Human immunodeficiency virus (HIV) antibody status and pneumococcal vaccine status were documented for less than 10% of the records and were not included in the analysis. Nosocomial infection was defined as a pneumococcal infection in a person hospitalized at UCDMC, a referring hospital, or skilled nursing facility during the 3-to 7-day period before the index blood culture. Immunosuppressed persons were persons with previously documented Pneumocystis carinii pneumonia, Mycobacterium avium-intracellulare infection, lymphoma, hematologic malignancy, or asplenia, or who received exogenous corticosteroids (-10 mg of prednisone per day), chemotherapy, or other immunosuppressive drugs. Adverse outcomes included death or mechanical ventilation from respiratory failure, ARDS during the index hospitalization or both. ARDS was a clinical diagnosis made by an attending UCDMC intensivist and defined by mechanical ventilation, increasing FI2 requirement, decreased lung compliance, and chest radiographs showing progressive bilateral infiltrates without evidence of cardiogenic pulmonary edema. Persons were followed up until the time of death or discharge from this index hospitalization.
Univariate Analysis
Continuous variables were analyzed with Student's t test. Significant continuous variables were dichotomized at the median value to calculate relative risk and for use in the logistic model. Each pulmonary and medical condition was analyzed independently and then grouped into "preexisting lung and medical diseases," respectively (Table 1) . Relative risk (RR) with exact 95% confidence intervals (95% CI), Mantel-Haenszel weighted relative risk (RRM-H), Fisher's exact test with two-tailed results, and Student's t test were calculated (with EPI-INFO).9 Rates with 95% CI were calculated (using Epistat).10
Multivariate Analysis
Significant factors from univariate analysis were included in a backward stepwise multivariate regression using a logistic model."'12 To select the best combination of risk factors predictive of adverse outcome, models were evaluated using a likelihood-ratio x2 statistic.13 For this statistical comparison, the number of persons within each nested model was appropriately adjusted.'2 Results are reported as an adjusted odds ratio with 95% CI. To evaluate the efficiency of the resulting model, there was a predicted probability of adverse outcome for each person." The probabilities were dichotomized (<0.50 and -0.50) and compared with the actual outcomes.
RESULTS

Mortality
During these 3 years, 102 persons with pneumococcal bacteremia and pneumonia were identified and included in the analysis. Of these, 78 Of 52 persons whose temperature was less than 380 C, 29 (56%; 95% CI, 41 to 70%) had an adverse outcome, resulting in a relative risk that was 2.1 (95% CI, 1.3 to 3.6) times greater than that of persons who presented with fever.
In addition to older age and lack of fever, five other conditions (preexisting lung disease, chronic obstructive pulmonary disease, history of pulmonary tuberculosis, preexisting medical disease, and nosocomial infection) were significantly associated with increased risk of adverse outcome in the univariate analysis (Table 2) .
Multivariate Analysis of Risk Factors
Four risk factors from the univariate analysis were independent and significantly contributed to a logistic model of adverse outcome (Table 2) . Preexisting medical disease was not included in the model because much of the associated risk found in the univariate analysis was attributable to age 248 years. Nosocomial infection had the greatest associated risk of adverse outcome (adjusted odds ratio, 17.3) and had a significant effect on the resulting model. Despite this elevated risk, the attributable risk associated with nosocomial infection is small because of the infrequent occurrence of this factor in the study.
A probability of adverse outcome was generated for each person. These probabilities were grouped into eight risk levels based on similar probabilities of outcome and compared with the actual rate of an adverse outcome (Table 3) had an adverse outcome (resulting in four deaths) during the index hospitalization. Persons with nosocomial infection or more than one of the four risk factors (risk levels C through H) had a calculated probability of an adverse outcome >0.5 (Table 3) . Of 49 persons with a probability >0.5,33 (67%; 95% CI, 52 to 80%) had an adverse outcome (resulting in 21 deaths) during the hospitalization. Model Efficiency A probability of adverse outcome was generated for each person. Using a threshold probability of 0.50, these probabilities were compared with the actual outcome of each person (Table 4) . Using clinical variables present during the evaluation of persons with lobar pneumonia, adverse outcome was correctly predicted, ie, positive predictive value, in 67% of the persons and a better outcome, ie, negative predictive value, was correctly predicted in 83% of the persons. DISCUSSION Overall, persons with pneumococcal bacteremia had 25% mortality, which is similar to the results of other studies performed in the antibiotic era.2'3'8 Mortality was not evenly distributed over this cohort. Only one death occurred among persons without any of four risk factors (age -48 years, initial temperature <38°C, preexisting lung disease, or nosocomial infection) resulting in 4% mortality. But, among the remaining persons, mortality was 31% and an additional 22% required mechanical ventilation.
Advanced age continues to be an overwhelming risk factor for death or respiratory failure due to pneumococcal pneumonia. Using a logistic model, much of the risk attributed to preexisting medical disease in univariate analyses was found to be actually due to age greater than 48 years. Austrian and Gold2 reported a mortality rate of 37.7% in persons 50 years or older with pneumococcal bacteremia compared with a 10.3% rate for those younger than 50 years. In previous studies, increased mortality was attributed to the increased frequency of more virulent pneumococcal serotypes and the waning antibody titer to these more virulent serotypes in older persons.2"14 Although serotyping was not done in this study, it is unlikely that the power would allow partitioning the risk due to specific serotypes of pneumococcus pneumonia from the risk of being elderly with sepsis. 15"6 Persons without fever were more likely to die or experience respiratory failure. Inappropriately low body temperature in the setting of infection has previously been thought to be a marker of either chronic illness or advanced age, but this logistic model suggests the risk from lack of fever was independent of these other two factors. In fact, preexisting diseases other than lung diseases played little role in outcome in the derived logistic model. Using can be associated with high mortality, S pneumoniae has been a rare cause of nosocomially acquired pneumonia. However, a recent report has suggested that up to 20% of nosocomial pneumonias may be due to pneumococcus.26 The high mortality of nosocomially acquired pneumococcus in this study suggests that pneumococci were more virulent serotypes, eg, serotype 3, or more resistant to antibiotics, or that recently infected persons had less nonspecific immunity. The association between multiply resistant pneumococci, virulent serotypes, and hospital-acquired infection has been well described in South Africa and Europe since the mid-1970s.27'28 In this study, blood culture isolates were routinely tested for oxacillin resistance using a disk diffusion method; no resistance was noted. Serotyping was not routinely performed and the risk attributable to serotype could not be compared with other risk factors.
Microbiologic isolation of S pneumoniae from sputum was associated with a 2.7 times greater risk for adverse outcome while the presence of Grampositive diplococci on Gram's stain of the sputum was not. Risk may be due to a greater burden of viable pneumococci that results from inadequate nonspecific response to pneumococcal infection such as secretory immunoglobulins to non-serotype-specific cell wall polysaccharide or surfactant protein A. Isolation of pneumococcus from the sputum was not included as a predictive variable because this information is not available during initial patient evaluation.
In this study, mortality for persons with pneumococcal bacteremia is similar to rates described by Austrian and Gold 30 years ago.2 Most of these deaths can be attributed to nosocomially acquired infection, two specific host factors (age and preexisting lung disease), and, possibly, inadequate nonspecific host response to pneumococcal infection. These four factors can be modeled to distinguish persons who may benefit from early, intensive care from those who are unlikely to require such care.
